ANROVSHAE• 28 Days (Normalized)
ANRO vs HAE (Alto Neuroscience Inc. vs Haemonetics Corporation)
Showing Closing Date Range from Sep 9 to Oct 7, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
ANRO Performance $23.69
-30.47%
Alto Neuroscience Inc.
Normalized Baseline0.00%
HAE Performance $103.52
+0.35%
Haemonetics Corporation
Normalized Baseline0.00%
Alpha Spread Margin HAE LEADS
-30.82 pts
HAE outperforming by 30.82 percentage points
ANROHAE
Spread Trajectory28 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
ANRO HAE
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(20 dates)
| Date | ANRO Price | ANRO Gain (%) | HAE Price | HAE Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 06, 2026 | $23.69 | -30.47% | $103.52 | +0.35% | -30.82% |
| Oct 05, 2026 | $24.01 | -29.53% | $104.68 | +1.47% | -31.00% |
| Oct 02, 2026 | $24.80 | -27.21% | $104.68 | +1.47% | -28.68% |
| Oct 01, 2026 | $- | $104.37 | +1.17% | - | |
| Sep 30, 2026 | $25.88 | -24.04% | $105.30 | +2.07% | -26.11% |
| Sep 29, 2026 | $26.58 | -21.98% | $105.80 | +2.56% | -24.54% |
| Sep 28, 2026 | $26.66 | -21.75% | $105.79 | +2.55% | -24.30% |
| Sep 25, 2026 | $26.49 | -22.25% | $105.30 | +2.07% | -24.32% |
| Sep 24, 2026 | $27.18 | -20.22% | $- | - | |
| Sep 23, 2026 | $27.50 | -19.28% | $106.82 | +3.55% | -22.83% |
| Sep 22, 2026 | $30.78 | -9.66% | $108.52 | +5.20% | -14.86% |
| Sep 21, 2026 | $30.63 | -10.10% | $108.73 | +5.40% | -15.50% |
| Sep 18, 2026 | $30.27 | -11.15% | $108.40 | +5.08% | -16.23% |
| Sep 17, 2026 | $30.98 | -9.07% | $107.60 | +4.30% | -13.37% |
| Sep 16, 2026 | $30.00 | -11.95% | $106.24 | +2.99% | -14.94% |
Page 1 of 2